Literature DB >> 19140229

Transient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence.

Frederique Caillot1, Celine Derambure, Paulette Bioulac-Sage, Arnaud Francois, Michel Scotte, Odile Goria, Martine Hiron, Maryvonne Daveau, Jean Philippe Salier.   

Abstract

AIM: To search for transcription dysregulation that could (1) differentiate hepatocellular carcinoma (HCC)-free from HCC-related cirrhosis (2) differentiate HCC-free cirrhosis related to HCV from that related to alcohol intake.
METHODS: Using microarray analysis, we compared transcript levels in HCC-free cirrhosis (alcoholism: 7; hepatitis C: 7), HCC-associated cirrhosis (alcoholism: 10; hepatitis C: 10) and eight control livers. The identified transcripts were validated by qRT-PCR in an independent cohort of 45 samples (20 HCC-free cirrhosis; 15 HCC-associated cirrhosis and 10 control livers). We also confirmed our results by immunohistochemistry.
RESULTS: In HCC-free livers, we identified 70 transcripts which differentiated between alcoholic-related cirrhosis, HCV-related cirrhosis and control livers. They mainly corresponded to down-regulation. Dysregulation of Signal Transduction and Activator of Transcription-3 (STAT-3) was found along with related changes in STAT-3 targets which occurred in an etiology-dependent fashion in HCC-free cirrhosis. In contrast, in HCC, such transcription dysregulations were not observed.
CONCLUSION: We report that transcriptional dysregulations exist in HCC-free cirrhosis, are transiently observed prior to detectable HCC onset and may be appear like markers from cirrhosis to HCC transition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19140229      PMCID: PMC2653326          DOI: 10.3748/wjg.15.300

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

Review 1.  Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes.

Authors:  P Ruminy; C Gangneux; S Claeyssens; M Scotte; M Daveau; J P Salier
Journal:  Inflamm Res       Date:  2001-08       Impact factor: 4.575

Review 2.  So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors.

Authors:  P S Subramaniam; B A Torres; H M Johnson
Journal:  Cytokine       Date:  2001-08-21       Impact factor: 3.861

3.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

4.  Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis.

Authors:  P Laurent-Puig; P Legoix; O Bluteau; J Belghiti; D Franco; F Binot; G Monges; G Thomas; P Bioulac-Sage; J Zucman-Rossi
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

5.  Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

Authors:  H Okabe; S Satoh; T Kato; O Kitahara; R Yanagawa; Y Yamaoka; T Tsunoda; Y Furukawa; Y Nakamura
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

6.  Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.

Authors:  Norio Iizuka; Masaaki Oka; Hisafumi Yamada-Okabe; Naohide Mori; Takao Tamesa; Toshimasa Okada; Norikazu Takemoto; Akira Tangoku; Kenji Hamada; Hironobu Nakayama; Takanobu Miyamoto; Shunji Uchimura; Yoshihiko Hamamoto
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

7.  Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.

Authors:  Yoshihiro Edamoto; Akira Hara; Wojciech Biernat; Luigi Terracciano; Gieri Cathomas; Hans-Martin Riehle; Masanori Matsuda; Hideki Fujii; Jean-Yves Scoazec; Hiroko Ohgaki
Journal:  Int J Cancer       Date:  2003-09-01       Impact factor: 7.396

8.  Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis.

Authors:  Norio Iizuka; Masaaki Oka; Hisafumi Yamada-Okabe; Naohide Mori; Takao Tamesa; Toshimasa Okada; Norikazu Takemoto; Kiichiro Hashimoto; Akira Tangoku; Kenji Hamada; Hironobu Nakayama; Takanobu Miyamoto; Shunji Uchimura; Yoshihiko Hamamoto
Journal:  Oncogene       Date:  2003-05-15       Impact factor: 9.867

Review 9.  Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas.

Authors:  Emily C Brantley; Etty N Benveniste
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

10.  Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein.

Authors:  Gary K Geiss; Victoria S Carter; Yupeng He; Bartlomiej K Kwieciszewski; Ted Holzman; Marcus J Korth; Catherine A Lazaro; Nelson Fausto; Roger E Bumgarner; Michael G Katze
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  7 in total

1.  Novel serum markers of fibrosis progression for the follow-up of hepatitis C virus-infected patients.

Authors:  Frédérique Caillot; Martine Hiron; Odile Goria; Marie Gueudin; Arnaud Francois; Michel Scotte; Maryvonne Daveau; Jean-Philippe Salier
Journal:  Am J Pathol       Date:  2009-05-28       Impact factor: 4.307

2.  The protective role of ellagitannins flavonoids pretreatment against N-nitrosodiethylamine induced-hepatocellular carcinoma.

Authors:  Rasha H Hussein; Fares K Khalifa
Journal:  Saudi J Biol Sci       Date:  2014-03-31       Impact factor: 4.219

3.  Effect of diosmin on apoptotic signaling molecules in N-nitrosodiethylamine-induced hepatocellular carcinoma in experimental rats.

Authors:  Srinivasan Perumal; Kulanthaivel Langeshwaran; Jayaraman Selvaraj; Rajagopal Ponnulakshmi; B Shyamaladevi; M P Balasubramanian
Journal:  Mol Cell Biochem       Date:  2018-02-26       Impact factor: 3.396

4.  Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse.

Authors:  Masataka Tsuge; Yoshifumi Fujimoto; Nobuhiko Hiraga; Yizhou Zhang; Mayu Ohnishi; Tomohiko Kohno; Hiromi Abe; Daiki Miki; Michio Imamura; Shoichi Takahashi; Hidenori Ochi; C Nelson Hayes; Fuyuki Miya; Tatsuhiko Tsunoda; Kazuaki Chayama
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

Review 5.  Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma.

Authors:  Ranjit Chauhan; Nivedita Lahiri
Journal:  Biomark Cancer       Date:  2016-07-04

6.  Computational identification of microRNAs and their targets in liver cirrhosis.

Authors:  Hongbo Du; Hao Yu; Yuying Yang; Yuanyuan Song; Fei Wang; Shangheng Li; Yuyong Jiang
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

Review 7.  ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets.

Authors:  Caroline C Duwaerts; Jessica L Maiers
Journal:  Front Mol Biosci       Date:  2022-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.